Insights

Growing Market Demand The increasing emotional value placed on pets and the desire for genetic preservation and cloning services suggest a rising demand segment, presenting opportunities for targeted marketing and expanding client outreach within high-income pet owner communities.

Strategic Industry Positioning As a leader in pet cloning and genetic preservation, Viagen Pets' recent acquisition by Colossal Biosciences indicates a strategic move to integrate advanced gene editing and species de-extinction technologies, opening avenues for cross-promotional collaborations and innovative service offerings.

Technological Infrastructure Utilizing robust cloud services like Amazon Web Services and Google Cloud positions Viagen Pets to scale operations efficiently and securely, providing opportunities to upsell data management and personalized client engagement solutions.

Premium Service Opportunities With high revenue figures and tailored preservation options, there is significant potential to develop premium or bundled packages, including long-term genetic storage and advanced cloning therapies, to attract high-net-worth clients seeking specialized pet care.

Industry Collaborations Collaboration prospects with veterinary clinics and pet care providers are ripe, especially in offering seamless sample collection for genetic preservation, enabling sales teams to expand outreach to veterinary professionals and pet health services.

Similar companies to Viagen

Viagen Tech Stack

Viagen uses 8 technology products and services including Amazon Web Services, Google Fonts API, Google Cloud, and more. Explore Viagen's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Google Fonts API
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Element UI
    Javascript Frameworks
  • Tailwind CSS
    UI Frameworks
  • Google Analytics
    Web Analytics
  • GTranslate
    Web Platform Extensions
  • Endurance Page Cache
    Web Platform Extensions

Viagen's Email Address Formats

Viagen uses at least 2 format(s):
Viagen Email FormatsExamplePercentage
First.Last@viagen.comJohn.Doe@viagen.com
89%
Last@viagen.comDoe@viagen.com
11%
First.Last@viagenpets.comJohn.Doe@viagenpets.com
100%

Frequently Asked Questions

Where is Viagen's headquarters located?

Minus sign iconPlus sign icon
Viagen's main headquarters is located at 715 Discovery Boulevard, Suite 410. The company has employees across 3 continents, including North AmericaSouth AmericaEurope.

What is Viagen's phone number?

Minus sign iconPlus sign icon
You can contact Viagen's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Viagen's stock symbol?

Minus sign iconPlus sign icon
Viagen is a publicly traded company; the company's stock symbol is CVCB3.SA.

What is Viagen's official website and social media links?

Minus sign iconPlus sign icon
Viagen's official website is viagenpets.com and has social profiles on LinkedIn.

What is Viagen's SIC code NAICS code?

Minus sign iconPlus sign icon
Viagen's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Viagen have currently?

Minus sign iconPlus sign icon
As of December 2025, Viagen has approximately 36 employees across 3 continents, including North AmericaSouth AmericaEurope. Key team members include Ceo: B. R.Coo: C. D.Chief Scientific Officer: S. W.. Explore Viagen's employee directory with LeadIQ.

What industry does Viagen belong to?

Minus sign iconPlus sign icon
Viagen operates in the Biotechnology Research industry.

What technology does Viagen use?

Minus sign iconPlus sign icon
Viagen's tech stack includes Amazon Web ServicesGoogle Fonts APIGoogle CloudElement UITailwind CSSGoogle AnalyticsGTranslateEndurance Page Cache.

What is Viagen's email format?

Minus sign iconPlus sign icon
Viagen's email format typically follows the pattern of First.Last@viagen.com. Find more Viagen email formats with LeadIQ.

When was Viagen founded?

Minus sign iconPlus sign icon
Viagen was founded in 2002.

Viagen

Biotechnology ResearchTexas, United States11-50 Employees

America’s Pet Cloning and Genetic Preservation Experts – Serving Pet Parents Worldwide

A beloved pet is much like a family member. The unique life-enriching bond, the love and companionship that grows, the way you feel for your pet; all are hard to replicate…until now. Today, safe genetic preservation and cloning of your dog or cat is an option pet owners may choose to explore for their healthy living pets, and for those pets that are nearing the end of their lives or have just passed away. Preservation and cloning with ViaGen Pets can allow you to reimagine and extend the very special love and experience you have with your pet to a genetic twin – a new adorable puppy or kitten that shares many of your original pet’s traits.  ViaGen Pets provides a cloning process that you can be confident is safe, and your pet’s DNA is not altered in any way. You can expect that your pet’s genetic twin will live a normal, healthy and happy life just like any other pet. You just provide the same love, companionship and care that you’ve always provided to your special pet.  If you’re unsure if cloning your pet is the right option for you, ViaGen Pets also provides long-term preservation of a sample of your current pet’s cells. Genetic preservation is one way to honor and memorialize your special pet by ensuring its genes will always exist, and can also be used for cloning later if you choose. Long-term storage of cells can also ensure access to future cell-based therapy options that don’t yet exist. A simple biopsy from your pet, performed by your veterinarian, is all that is required to get started.

Contact us today at 888-876-6104.

Section iconCompany Overview

Headquarters
715 Discovery Boulevard, Suite 410
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CVCB3.SA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2002
Employees
11-50

Section iconFunding & Financials

  • $25M$50M

    Viagen's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Viagen's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.